Your institution may have access to this item. Find your institution then sign in to continue.
Title
Erratum.
Abstract
A correction to the article "Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR" by Myung-Ju Ahn, Sang-We Kim and Byoung-Chul Cho is presented.